NGNE · Neurogene Inc.

NasdaqHealthcareBiotechnology

Neurogene Inc Is A Clinical-Stage Biotechnology Company Committed To Overcoming The Limitations Of Neurological Diseases Into Treatable Conditions, By Harnessing Its Proprietary Transgene Regulation Technology, Exact(Expression Attenuation Via Construct Tuning). It Is Building A Differentiated Product Portfolio Of Genetic Medicines For Rare Neurological Diseases With High Unmet Needs. The Drug Candidates In The Company'S Product Pipeline Include Ngn-401, Which Is In Development For The Treatment Of Rett Syndrome, Using Its Exact Platform, And Ngn-101, A Non-Exact, Conventional Gene Therapy Development Candidate For The Treatment Of Cln5 Batten Disease, Designed To Deliver The Cln5 Gene And Packaged In An Aav9 Capsid.

HealthcareNasdaqUSLow Float

FLOAT

12.9M

FREE FLOAT %

64%

SHARES O/S

20.0M

MARKET CAP

$471.3M

EXCHANGE

Nasdaq

COUNTRY

NGNE Catalyst History

No catalysts recorded for NGNE yet

Day Trader Sniper hasn't classified a publishable catalyst for NGNE yet. New events appear here as they're scored.

Be early on the next NGNE spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

NGNE · Neurogene Inc.

NGNE Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.